Evidence map›Paper›PMID 30363950›Full record

ArticleCardiology research and practice2018

Echo- and B-Type Natriuretic Peptide-Guided Follow-Up versus Symptom-Guided Follow-Up: Comparison of the Outcome in Ambulatory Heart Failure Patients.

Gani Bajraktari, Nicola Riccardo Pugliese, Andreina D'Agostino, Gian Marco Rosa, Pranvera Ibrahimi, Luan Perçuku, Mario Miccoli, Gian Giacomo Galeotti, Iacopo Fabiani, Roberto Pedrinelli and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cardiology research and practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Recommendations for Lung Ultrasound in Internal Medicine.Diagnostics (Basel, Switzerland) · 2020
    Guideline
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Gani BajraktariDepartment of Public Health and Clinical Medicine, Umeå University and Heart Centre, Umeå, Sweden.
Nicola Riccardo PuglieseCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy.ORCID 0000-0002-5473-227X
Andreina D'AgostinoCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy.
Gian Marco RosaDepartment of Internal Medicine, University of Genoa, Genoa, Italy.
Pranvera IbrahimiDepartment of Public Health and Clinical Medicine, Umeå University and Heart Centre, Umeå, Sweden.
Luan PerçukuClinic of Cardiology, University Clinical Centre of Kosova, Prishtina, Kosovo.
Mario MiccoliDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Gian Giacomo GaleottiCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy.ORCID 0000-0002-3170-6618
Iacopo FabianiCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy.ORCID 0000-0002-0645-4711
Roberto PedrinelliCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy.ORCID 0000-0001-7745-3890
Michael HeneinDepartment of Public Health and Clinical Medicine, Umeå University and Heart Centre, Umeå, Sweden.
Frank L DiniCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy.ORCID 0000-0003-1458-4820
University of Pisa · ITUniversity Clinical Center of Kosovo · XKUmeå University · SEUniversity of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent European Society of Cardiology and American Heart Association/American College of Cardiology Guidelines did not recommend biomarker-guided therapy in the management of heart failure (HF) patients. Combination of echo- and B-type natriuretic peptide (BNP) may be an alternative approach in guiding ambulatory HF management. Our aim was to determine whether a therapy guided by echo markers of left ventricular filling pressure (LVFP), lung ultrasound (LUS) assessment of B-lines, and BNP improves outcomes of HF patients. Consecutive outpatients with LV ejection fraction (EF) ≤ 50% have been prospectively enrolled. In Group I (

Identifiers

PMID30363950
PMCPMC6186350
OpenAlexW2893547232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.